a b s t r a c t CHARGE syndrome is caused by spontaneous loss-of-function mutations to the ATP-dependant chromatin remodeller chromodomain-helicase-DNA-binding protein 7 (CHD7). It is characterised by a distinct pattern of congenital anomalies, including cardiovascular malformations. Disruption to the neural crest lineage has previously been emphasised in the aetiology of this developmental disorder. We present evidence for an additional requirement for CHD7 activity in the Mesp1-expressing anterior mesoderm during heart development. Conditional ablation of Chd7 in this lineage results in major structural cardiovascular defects akin to those seen in CHARGE patients, as well as a striking loss of cardiac innervation and embryonic lethality. Genome-wide transcriptional analysis identified aberrant expression of key components of the Class 3 Semaphorin and Slit-Robo signalling pathways in Chd7 fl/fl ;Mesp1-Cre mutant hearts. CHD7 localises at the Sema3c promoter in vivo, with alteration of the local chromatin structure seen following Chd7 ablation, suggestive of direct transcriptional regulation. Furthermore, we uncover a novel role for CHD7 activity upstream of critical calcium handling genes, and demonstrate an associated functional defect in the ability of cardiomyocytes to undergo excitation-contraction coupling. This work therefore reveals the importance of CHD7 in the cardiogenic mesoderm for multiple processes during cardiovascular development.
Introduction
Heart development involves a series of tightly-regulated morphological changes, from the early establishment of a linear tube to looping, chamber formation, and septation (Buckingham et al., 2005) . The importance of epigenetic regulation of gene expression programmes during this complex process is becoming increasingly apparent, with a range of chromatin-remodelling and histonemodifying factors now identified with roles in cardiovascular development and disease (Chang and Bruneau, 2012) . Chromodomain-helicase-DNA-binding protein 7 (CHD7) is a large ATP-dependant nucleosome-remodelling protein. It co-localises with mono-and tri-methylated lysine 4 on histone H3 (Schnetz et al., 2009) , and shows a high level of co-occupancy with p300 binding sites in embryonic stem cells, indicating it may regulate gene expression through enhancer-binding (Schnetz et al., 2010) . Chromatin remodelling by CHD7 is involved in the transcriptional regulation of key developmental processes, including great vessel morphogenesis (Randall et al., 2009) , neural crest cell (NCC) formation (Bajpai et al., 2010) , and neuronal differentiation (Engelen et al., 2011; Layman et al., 2009) .
Haploinsufficiency for CHD7 causes human CHARGE syndrome in over 90% of clinical cases (Vissers et al., 2004) . CHARGE is a developmental disorder characterised by a specific pattern of defects, including ocular coloboma, heart malformations, atresia of the choanae, growth retardation, genital hypoplasia and ear abnormalities (Hall, 1979) . A wide range of congenital heart defects are seen in approximately 74-77% of CHARGE patients (Zentner et al., 2010; Corsten-Janssen et al., 2013) , with an overrepresentation of atrioventricular septal defects (AVSDs) and outflow tract (OFT) defects (Corsten-Janssen et al., 2013) . CHD7 mutations have also been detected in a large-scale study of de novo mutations in human sporadic congenital heart defects (Zaidi et al., 2013) .
Investigation of Chd7-null embryos indicates that CHD7 interacts with BMP-activated SMAD1/5/8 to regulate expression of cardiogenic BMP target genes such as Nkx2.5, Gata4 and Tbx20 during early cardiogenesis and chamber formation (Liu et al., Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology 2014). However, Chd7 À / À mouse mutants die at embryonic day (E) 10.5 due to p53-dependant growth failure (Van Nostrand et al., 2014) , limiting a full assessment of heart development. Chd7 þ / À mice are viable and phenocopy a number of aspects of CHARGE syndrome, including partial penetrance of ventricular septal defects (VSDs) and interrupted aortic arch type B (IAA-B) (Randall et al., 2009; Bosman et al., 2005; Hurd et al., 2007) , although the full spectrum and severity of CHARGE cardiovascular malformations are not seen. We have therefore utilised a conditional knockdown model to investigate further the role of CHD7 and its tissue-specific requirements during heart development.
There are three known developmental origins for the cells that make up the mature heart: the cardiogenic mesoderm, from which the myocardium and endocardium are derived (Saga et al., 1999) ; cardiac NCCs, which contribute to OFT septation and great vessel development (Creazzo et al., 1998; Waldo et al., 2005) ; and the proepicardial organ, which provides components of the coronary vasculature system (Merki et al., 2005) . CHARGE syndrome is often classified as a disease arising from maldevelopment of NCCs, known as a neurocristopathy (Etchevers et al., 2006) , and CHD7 activity has been shown to have an essential role in the activation of the NCC transcriptional circuitry (Bajpai et al., 2010) . We show for the first time that loss of Chd7 in the early cardiogenic mesoderm, driven by Mesp1-Cre, results in major structural defects and gene dysregulation, leading to cardiac failure and embryonic lethality around E15.5. Endocardial-specific ablation of Chd7 also results in septation and great vessel defects, indicating disruption to endocardium development is contributing to these malformations. CHD7 action lies upstream of key extracellular signalling molecules, including components of the Semaphorin and Slit-Robo pathways, as well as cardiac calcium handling genes, with consequences for excitation-contraction coupling in cardiomyocytes. Together, these results indicate that disruption to CHD7 activity in the cardiogenic mesoderm significantly contributes to the cardiovascular malformations seen in CHARGE patients.
Results and discussion

Embryonic lethality and great vessel defects following mesodermal ablation of Chd7
Mice homozygous for a conditional floxed Chd7 allele (Chd7 fl/fl ) were crossed with Chd7 fl/ þ ;Mesp1-Cre mice, to homozygously ablate Chd7 expression in the anterior mesoderm (Supplemental Fig. S1 ). Mesp1-Cre is expressed from E6.5 in the pharyngeal and cardiac mesoderm, including both the first and second heart fields of mesodermal cardiac progenitors (Saga et al., 1999) , and in situ hybridisation (ISH) confirmed loss of Chd7 mRNA throughout the heart in E11.5 Chd7 fl/fl ;Mesp1-Cre embryos (Supplemental Fig. S2 ). No liveborn Chd7 fl/ fl ;Mesp1-Cre pups were produced from this cross, and at E18.5 the number of Chd7 fl/fl ;Mesp1-Cre embryos collected were significantly below their expected Mendelian ratios ( Supplemental Table S1 ). Approximately three-quarters of Chd7 fl/fl ;Mesp1-Cre embryos survived to E15.5, although over 90% (n¼22) showed severe oedema and/or haemorrhaging, indicative of cardiac failure (Fig. 1A ). This conditional model therefore bypasses the p53-dependant developmental delay and early embryonic lethality seen with constitutive Chd7 À /À mutants, allowing a fuller assessment of heart development and investigation into the role of CHD7 in septation and great vessel remodelling.
Examination of the great arteries at E15.5 revealed that 21% (n ¼14) of Chd7 fl/fl ;Mesp1-Cre embryos had interrupted aortic arch type B (IAA-B, Fig. 1B ), compared to just 4% of heterozygous genetrapped Chd7 xk/ þ embryos (Randall et al., 2009) . The great vessel defects in Chd7 xk/ þ mutants were attributed to earlier pharyngeal arch artery (PAA) malformations seen at E10.5, and Chd7 expression in the pharyngeal surface ectodermbut not the mesodermwas shown to be required for this early PAA morphogenesis (Randall et al., 2009 ). However, the PAAs were formed normally in all E10.5 Chd7 fl/fl ;Mesp1-Cre embryos examined (n ¼14, Fig. 1C ), presumably as the ectodermal expression of Chd7 is unaffected in this genotype. Instead, the IAA-Bs seen at E15.5 were likely due to a later PAA remodelling defect, indicating that Chd7 is required in mesodermal derivatives for remodelling of the OFT and PAAs to form the mature configuration of the aortic arch and great vessels. 
Major septation defects affect both the arterial and venous poles
Correct alignment and septation of the developing cardiac components ensures the complete separation of the pulmonary and systemic circulations, which is vital for effective cardiovascular function. Haematoxylin and eosin (H&E) staining of sections showed major structural defects in Chd7 fl/fl ;Mesp1-Cre hearts (summarised in Fig. 2A and Table 1 ). Sixty percent of hearts examined at E15.5 (n¼ 10) had double outlet arising from the right ventricle (DORV, Fig. 2B ), and common arterial trunk (CAT) was seen in one Chd7 fl/fl ;Mesp1-Cre embryo at E13.5 (n ¼10, Fig. 2C ).
Whilst these malformations are indicative of an abnormality in the addition of second heart field (SHF)-derived cells to the arterial pole, Islet-1 staining showed similar distributions of undifferentiated SHF progenitors in the developing OFTs of control Chd7 fl/fl and mutant Chd7 fl/fl ;Mesp1-Cre hearts (Supplemental Fig.  S3 ). It may therefore be the subsequent differentiation of these SHF-derived cells in Chd7 fl/fl ;Mesp1-Cre hearts that is underlying the observed OFT defects.
All hearts examined at E15.5 also had double inlet left ventricle (DILV, Fig. 2D ), a severe form of AVSD whereby both atria are connected through a common atrioventricular (AV) valve to a . The bar graph shows the mean thickness of the compact and trabecular layers of the ventricles, indicating that the overall thickness of both the right and left ventricles was significantly reduced in Chd7 fl/fl ;Mesp1-Cre hearts. The percentage of the overall wall thickness that each layer comprised is also indicated on the graph, showing the compact layer is particularly affected in the left ventricle of the mutants. nn p o0.01 (calculated using unpaired student t test). Scale bars represent 0.5 mm. ao indicates aorta; pt, pulmonary trunk; ra/la, right/left atrium; rv/lv, right/left ventricle; ivs, inter-ventricular septum.
dominant left ventricle, with no access from the AV junction to the incomplete right ventricle. Related to this malformation, an interventricular communication was observed in all hearts, and the venous valves were absent or poorly formed. Furthermore, the ventricular mural myocardium was poorly compacted in Chd7 fl/fl ; Mesp1-Cre hearts ( Fig. 2E ), although the development of the epicardium looked normal (Supplemental Fig. S4 ).
The presence of AVSD and common AV valves is indicative of a failure of the vestibular spine (also known as the dorsal mesenchymal protrusion) to form at the venous pole of the heart. It is this spine that drives the separation of the AV canal into its left and right components and carries forward the inferior ends of the venous valves (Anderson et al., 2003) . To investigate this further, optical projection tomography (OPT) was used to examine hearts at E11.5, which showed the vestibular spine was absent or reduced in size in Chd7 fl/fl ;Mesp1-Cre hearts (Fig. 3A ). This imaging also showed grossly abnormal positioning of the endocardial cushions, which were markedly rotated within the AV canal compared to the control hearts ( Fig. 3B ). These local tissue swellings contribute to the septation of the chambers to form the functional four-chambered heart, and a hypocellular AV cushion defect has been reported in Chd7-null embryos at E9.5 and E10.5 (Liu et al., 2014) . Despite their abnormal positioning, a similar hypocellular defect was not seen in the cushions of Chd7 fl/fl ;Mesp1-Cre hearts at E10.5 or E11.5 ( Fig. 3C and Supplemental Fig. S5 ), indicating that mesenchymal population of the cushions is not affected in these conditional mutants.
The great vessel, OFT and septation defects we observed in Chd7 fl/fl ;Mesp1-Cre hearts correlate well with the reported clinical CHARGE malformations (Corsten-Janssen et al., 2013) . However, whilst AVSD is commonly seen, DILV is not usually associated with CHARGE syndrome. This difference likely reflects dosage dependence for Chd7 expression, with homozygous deletion of Chd7 in the mesoderm resulting in a greater reduction in CHD7 activity than occurs in CHARGE patients. Similarly, lack of haploinsufficiency in our heterozygous mesodermal conditional mutants indicates that hemizygosity for the CHD7 protein is required in multiple tissue types for the CHARGE phenotype to become manifest. Interestingly, this combination of DILV with concordant ventriculo-arterial connections seen in the Chd7 fl/fl ;Mesp1-Cre hearts is analogous to the extremely rare condition in humans known as the "Holmes heart" (Dobell and Van Praagh, 1996) .
Defective cardiac innervation and coronary vein development
To characterise further the cardiac phenotype following mesodermal Chd7 ablation, the innervation and vascularisation of these hearts was investigated. Wholemount immunostaining for Neurofilament-66 showed major truncation of the neuronal axons innervating Chd7 fl/fl ;Mesp1-Cre hearts (Fig. 4A ). Both sympathetic and parasympathetic axons can be seen on the dorsal surface of the heart by E15.0, although they are predominantly sympathetic (Nam et al., 2013) . They are derived from NCCs, which migrate to the dorsal aorta, differentiate into neurons and extend axonal projections into the cardiac tissue (Hasan, 2013) . As Chd7 expression is not deleted in NCCs in Chd7 fl/fl ;Mesp1-Cre embryos, this is indicative of a non-cell autonomous effect of mesodermal Chd7 knockdown on the NCCs or neurons that contribute to cardiac innervation.
Major disruption to the coronary veins on the dorsal surface of the heart was also seen at E15.5 in Chd7 fl/fl ;Mesp1-Cre hearts by anti-Endomucin immunostaining, with either severe truncation of vessels or ectopic formation of multiple small veins ( Fig. 4B ). However, the coronary veins formed normally when Chd7 was ablated specifically in endothelial cells using Tie2-Cre (Fig. 4C ). Therefore, CHD7 activity within the myocardium again appears to have a non-cell-autonomous effect on the migratory endothelial cells required for the development of the coronary veins, presumably through transcriptional effects on extracellular guidance signalling from the myocardium to the venous endothelial cells.
Dissecting the role of CHD7 in the endocardium
The septation and trabeculation defects observed in Chd7 fl/fl ; Mesp1-Cre hearts could be due to abnormal development of the endocardium and its derivatives. We therefore addressed the importance of CHD7 activity in this lineage by utilising the pan-endothelial marker Tie2-Cre (Kisanuki et al., 2001) to drive endocardial-specific Chd7 ablation. Chd7 fl/fl ;Tie2-Cre offspring were viable, and significantly fewer Chd7 fl/fl ;Tie2-Cre embryos collected at E15.5 showed oedema compared with Chd7 fl;fl ;Mesp1Cre embryos (see Table 2 and Fig. 5A ). Furthermore, none showed haemorrhaging, indicating that CHD7 activity is not required cell autonomously for vessel integrity. Some great vessel and septation defects were present ( Fig. 5B-C) , and three out of eight Chd7 fl/fl ; Tie2-Cre embryos showed a similar myocardial non-compaction defect to Chd7 fl;fl ;Mesp1-Cre hearts. However, these malformations were seen at a lower penetrance and without the accompanying alignment defects seen following Mesp1-Cre-driven ablation. There were also no examples of DORV or CAT seen in Chd7 fl/fl ;Tie2-Cre embryos, suggesting that CHD7 activity in the endocardium is not involved in arterial pole septation.
Together, this data indicates that there is indeed a role for Chd7 in the endocardium for AV canal septation and compaction of the myocardial walls. However, as the full Chd7 fl/fl ;Mesp1-Cre cardiac phenotype is not recapitulated in Chd7 fl/fl ;Tie2-Cre hearts, it may not be the only underlying mechanism. Reciprocal interactions between the endocardium and myocardium, which are both derived from Mesp1-expressing progenitors, are crucial during heart development (Tian and Morrisey, 2012) . Therefore, it is likely the increased severity and frequency of defects seen in Chd7 fl/fl ;Mesp1-Cre hearts is due to a requirement for CHD7 activity in both lineages. Furthermore, as Tie2-Cre also marks the venous precursors of the lymphatic vasculature (Srinivasan et al., 2007) , the absence of haemorrhage and the low penetrance of oedema in Chd7 fl/fl ;Tie2-Cre conditionals is not supportive of a major role for CHD7 in lymphatic development. Instead, poor cardiac function is most likely to be underlying these phenotypes in Chd7 fl/fl ;Mesp1-Cre embryos.
Differential gene expression following mesodermal Chd7 ablation
To investigate the global transcriptional changes underlying the observed cardiovascular defects, microarrays were performed on mRNA extracted from dissected Chd7 fl/fl ;Mesp1-Cre versus Chd7 þ / þ ;Mesp1-Cre hearts. Gene expression was examined at both E11.5 and E13.5, when the growth of the vestibular spine, development of the endocardial cushions, and septation is normally occurring. Crucially, most cardiovascular defects occurred later in our conditional model than on the background of global Chd7 knockdown and gross developmental delay, with no major loss of tissue or hypocellular phenotype in either E10.5 or E11.5 Chd7 fl/fl ;Mesp1-Cre hearts. Therefore, our analysis of a role for CHD7 subsequent to its previously-reported BMP-dependant role upstream of Nkx2.5 should not be compromised by earlier defects (Liu et al., 2014) . Furthermore, Western blot analysis of CHD7 protein in dissected wild-type hearts showed CHD7 was detectable until E13.5, whilst nuclear CHD7 protein was observed by immunohistochemistry throughout wild-type hearts at E10.5 and E11.5 (Supplemental Fig. S6 ). This indicates a later role for CHD7 in cardiovascular development than can be examined in constitutive Chd7 À / À mutants. Full lists of genes with altered expression (log 2 FC40.5, po0.05) in the heart at E11.5 or E13.5 following mesodermal deletion of Chd7 are available in Supplemental Table S2 . Multiple testing correction using the Benjamini-Hochberg procedure identified 31 genes that were significantly downregulated and 20 genes upregulated at E11.5, whilst 6 genes were downregulated and 3 upregulated at E13.5 (log 2 FC40.5, adj. po0.05-see Table 3 ). This is consistent with previous reports that chromatin remodelling by CHD7 acts as a "transcriptional rheostat" to modulate the expression of its target genes in either a positive or negative direction (Schnetz et al., 2010) . Gene ontology (GO) term clusters generated using the DAVID Bioinformatics resource (Huang et al., 2009 ) highlighted a number of processes relevant for later cardiac development and the defects observed in the Chd7 fl/fl ;Mesp1-Cre hearts ( Supplemental Tables  S3-6) . Interestingly, many of the GO clusters involved extracellular signalling pathways, such as cell surface receptor linked signal transduction and G-protein coupled receptor signalling pathways, rather than direct transcriptional regulators such as Nkx2.5 and Tbx20, which are downregulated in earlier Chd7-null hearts (Liu et al., 2014) .
We chose to investigate further components of the Semaphorin and Slit-Robo extracellular signalling pathways that were disrupted in the microarray datasets, alongside genes involved in the excitation-contraction coupling of cardiomyocytes, due to their known roles in cardiovascular development and relevance to the observed defects in Chd7 fl/fl ;Mesp1-Cre hearts (see Supplemental  Table S7 ).
Disruption to Class 3 Semaphorin and Slit-Robo signalling pathways
The signalling glycoprotein Semaphorin 3A, encoded by Se-ma3a, acts as a potent neural chemorepellent and has a key role in sympathetic innervation patterning of the heart: homozygous null Sema3a À / À mice show disruption to cardiac innervation leading to sinus bradycardia (Ieda et al., 2007) . Sema3a expression was significantly downregulated in both the E11.5 and E13.5 microarray datasets (Table 3) , and RT-PCR and ISH confirmed the trabecular expression of Sema3a seen at E13.5 was drastically reduced following mesodermal Chd7 ablation ( Fig. 6A and B) . This downstream loss of Sema3A expression may be contributing to the innervation defects seen in Chd7 fl/fl ;Mesp1-Cre hearts. Alternatively, given the location of its expression at this stage, it may be influencing the trabeculation and compaction of the ventricles, which are also affected in Chd7 fl/fl ;Mesp1-Cre hearts.
Loss-of-function mutations of SEMA3A are associated with human Kallmann Syndrome (Hanchate et al., 2012) , a disorder having defects overlapping with CHARGE. Of interest, non-synonymous SEMA3A variations have been found in 3 of 45 CHD7-negative CHARGE patients, and Sema3a expression is lost after morpholinoknockdown of Chd7 in Xenopus (Schulz et al., 2014) . This work therefore strengthens the link between CHD7 and SEMA3A and indicates it is relevant in the context of heart development and cardiac innervation. Furthermore, it is in agreement with, and extends, a recent report that Sema3a and Sema3c have diminished expression in whole E9.5 Chd7 À / À embryos (Schulz et al., 2014) . Downregulation of Sema3c expression was also seen in the microarrays and qRT-PCR validation. ISH at E11.5 confirmed Se-ma3c expression is specifically lost in the myocardial cuff at the distal end of the OFT in Chd7 fl/fl ;Mesp1-Cre hearts (Fig. 6C) . Notably, Sema3c -/embryos have defects in the morphogenetic patterning of the aortic arch and OFT that significantly overlap with Chd7 fl/fl ; Mesp1-Cre hearts, including CAT, DORV and IAA-B (Feiner et al., 2001) . Earlier PAA formation is also unaffected in these embryos, as we observe in Chd7 fl/fl ;Mesp1-Cre embryos. Chromatin immunoprecipitation (ChIP) for CHD7 followed by qRT-PCR performed on chromatin from dissected E11.5 hearts showed enrichment for CHD7 specifically at the promoter region of Sema3c ( Fig. 6D and E) . DNase I hypersensitivity assays, designed to test the accessibility of this region of DNA as a readout of chromatin remodelling activity, also showed a significant reduction in sensitivity to increasing concentrations of DNase I in Chd7 fl/fl ;Mesp1-Cre hearts (Fig. 6F) . This is the first direct target for CHD7 regulation in the heart to be identified in vivo, and supports our proposal that diminished Semaphorin 3C signalling in the OFT contributes to the defects seen in Chd7 fl/fl ;Mesp1-Cre hearts.
A number of components of the Slit-Robo signalling pathway were similarly downregulated following Chd7 ablation, including Slit2, Robo2, Slitrk5 and Slitrk6 (Fig. 7A-C) . The Slit and Robo protein families participate together in repulsive or attractive signalling to a range of migrating cells, including neurons (Rothberg et al., 1988) , muscle precursors (Kramer et al., 2001) , and endothelial cells ). The observation of truncated coronary veins after mesodermal, but not endothelial, deletion of Chd7 therefore may be attributed, at least in part, to downregulation of Slit-Robo signalling from cardiomyocytes to migratory endothelial cells. Class 3 Semaphorin and Slit-Robo signalling have been shown to act synergistically for directional control of neuronal migration in the context of both ventral forebrain and corneal innervation (Hernandez-Miranda et al., 2011; Kubilus and Linsenmayer, 2010) . The compound effect of disruption to components of both pathways could therefore impact on the innervation defects present in Chd7 fl/fl ;Mesp1-Cre hearts. Furthermore, the Slit-Robo pathway is crucial for ventricular septation, with VSDs observed at E14.5 in mice mutant for Slit2, Slit3, Robo1 and Robo1/Robo2 double mutants (Mommersteeg et al., 2015) . Also of note, reduced outflow tract rotation was observed in the Robo1/ Robo2 mutants (Mommersteeg et al., 2015) . Table 3 Genes identified through microarray analysis with differential expression in Chd7 fl/fl ;Mesp1-Cre hearts following multiple testing correction (log 2 FC40.5, adj.p.value o 0.05). Together, this data indicates CHD7 activity has a role upstream of the key Semaphorin and Slit-Robo extracellular signalling pathways in the heart around E11.5-E13.5, with CHD7 binding observed in vivo at the promoter of Sema3c suggesting direct regulation. Unfortunately, due to technical difficulties attempts at in vivo ChIP-seq or ChIP-PCR at other candidate loci were unsuccessful, so it remains to be determined whether other gene expression changes are the result of direct CHD7 activity. Table S7 shows the microarray results for these genes for comparison. (B) At E13.5, trabecular expression of Sema3A was seen by ISH on control Chd7 fl/fl sections, with significant reduction in Chd7 fl/fl ;Mesp1-Cre hearts (red stars). (C) ISH at E11.5 showed Sema3C expression in the myocardial cuff (blue arrows), which was strongly downregulated at the distal end of the OFT in Chd7 fl/fl ;Mesp1-Cre hearts (red arrows). Sema3C expression in the cardiac neural crest was also slightly reduced in mutants (white arrows). (D) ENCODE data around the Sema3c locus was used to design primer sets (denoted in red) to overlap with areas of DNase I hypersensitivity and histone modification marks associated with suspected promoter and enhancer regions. (E) ChIP-PCR demonstrated CHD7 binding around the promoter of Sema3C at E11.5 using Primer pair 1. (F) DNase I hypersensitivity assay showed greater chromatin compaction in Chd7 fl/fl ;Mesp1-Cre hearts (dotted line) than littermate controls (solid line) at the Sema3c promoter. Little change was seen at the Gapdh or Nanog promoters, although Gapdh displayed greater hypersensitivity, correlating with its constitutive expression. Individual replicates are shown, as it was not possible to normalise across separate experiments. n p o 0.05, nn po 0.01 (unpaired student t test). Scale bars represent 0.2 mm. oft indicates outflow tract; rv, right ventricle; lv, left ventricle. In addition to the major morphological events involved in heart development, the ability of cardiomyocytes to undergo coordinated excitation-contraction coupling is essential for cardiovascular function. The ubiquitous messenger Ca 2 þ is the key signalling molecule for this process (Bers, 2002) . Transcripts for the sarcoplasmic reticulum (SR) membrane-associated Casq2, Trdn and Ryr3, which play key roles in Ca 2 þ -induced Ca 2 þ release during excitation-contraction coupling, were dysregulated, along with the L-type voltage-dependant Ca 2 þ channels Cacng7, Cacna2d3 and Cacna1e (see Table S7 and Fig. 8A) .
Ensembl ID
To determine whether the sum of these moderate transcriptional changes correlated with any functional effect, Ca 2 þ transients were visualised in embryonic cardiomyocytes ex vivo, using confocal microscopy for line scanning of individual cells over time ( Fig. 8B and C) . A striking difference was observed in the response to electrical field stimulation at 1 Hz between control (Chd7 fl/fl or Chd7 fl/ þ ) and Chd7 fl/fl ;Mesp1-Cre cardiomyocytes: 95% (n ¼22) of control cells responded to electrical pacing with regular Ca 2 þ transients recorded at the expected 1 s intervals, but only 39% (n ¼23) of Chd7 fl/fl ;Mesp1-Cre cells could be paced in this way (p o0.0001, Fig. 7D,E) . This indicates the excitation-contraction coupling mechanism in cardiomyocytes is defective following ablation of Chd7 in the cardiogenic mesoderm.
The loss of coordinated excitation-contraction coupling would be a major contributing cause of cardiac failure, which is likely underlying the severe oedema and embryonic lethality seen in Chd7 fl/fl ;Mesp1-Cre embryos. The importance of this cardiac failure is emphasised given the low level of oedema seen in Chd7 fl/fl ;Tie2-Cre embryos, as previously discussed. Ca 2 þ signalling is also an important factor in regulating cardiac morphogenesis, for example through secretion of cardiogenic signalling molecules and force generation (Puceat and Jaconi, 2005) . To our knowledge, dysregulation of Ca 2 þ handling genes has not been remarked upon in any other transcriptomics analysis of hearts mutant for chromatin regulators. Interestingly, however, embryos mutant for the splicing Table S7 shows the microarray results for these genes. (B) Immunocytochemistry showed cardiacspecific myosin heavy chain 6 (MHC6) and nuclear NKX2-5 levels in isolated E13.5 cardiomyocytes. (C) Rapid line scan analysis of Ca 2 þ transients over 40 s in individual cardiomyocytes showed irregular contractions, which could be paced using electrical field stimulation at 1 regulator SRp38 also show disruption to Trdn and Calq2 transcripts, leading to abnormal Ca 2 þ release from the SR and structural cardiac defects markedly similar to those seen in Chd7 fl/fl ; Mesp1-Cre hearts (Feng et al., 2009 ). Transcriptional changes to these genes and the resulting disruption to Ca 2 þ signalling therefore also likely contribute to the structural malformations observed in Chd7 fl/fl ;Mesp1-Cre hearts.
Conclusions
We have demonstrated a crucial role for CHD7 activity in the mesodermal lineage for the alignment, septation and maturation of the heart, as well as cardiac innervation, vascularisation, and remodelling of the great vessels. Ablation of Chd7 in the cardiogenic mesoderm is sufficient to produce major structural defects and disrupted cardiomyocyte function, with the bypass of early lethality allowing the exploration of global transcriptional effects on later heart development. This analysis indicated a switch in the types of genes CHD7 regulates (directly or indirectly) as cardiogenesis progresses, from transcription factors such as NKX2-5, to extracellular signalling and Ca 2 þ handling genes. Furthermore, Sema3c is identified as a novel direct target of CHD7 in the developing heart in vivo. Therefore, disruption to transcriptional networks in both the cardiac neural crest and cardiogenic mesoderm likely contribute to the cardiovascular defects seen in CHARGE patients due to haploinsufficient loss of CHD7 activity.
Materials and methods
Further details of Materials and methods are included in the Supplemental material.
Mouse lines
Animal maintenance, husbandry and procedures were carried out in accordance with British Home Office regulations. The mouse lines used were: conditional Chd7 fl (MGI: 4433295, Chd7 tm2a(EU-
COMM)Wtsi
), Mesp1-Cre (MGI: 2176467, Mesp1 tm2(cre)Ysa ), and Tie2-Cre (MGI: 2450311,Tg(Tek-cre)1Ywa). All lines were maintained on a C57Bl/6 J background. CD1 mice were used for CHD7 immunofluorescence and ChIP experiments. The date of observation of a vaginal plug was considered embryonic day E0.5.
Optical projection tomography
Embryos were fixed overnight in 4% PFA/PBS and mounted in low-melting agarose (Life Technologies). Samples were then trimmed and washed in 100% methanol followed by clearing in 2BA:1BB (2 parts benzyl alcohol to 1 part benzyl benzoate), before analysis using a Bioptonics OPT Scanner 3001M (MRC Technology, Edinburgh, UK). NRecon software (Skyscan NV) was used for image reconstruction from projections using a back-projection algorithm, and ImageJ was used for image analysis.
Microarrays
E11.5 or 13.5 hearts were dissected into RNase-free PBS and stored in Buffer RLT (Qiagen) at À 80°C until genotyped. Total RNA was isolated using RNeasy Mini kits (Qiagen), including the optional on-column DNase digestion step. Sense-strand cDNA was generated using the Ambion s WT Expression Kit and processed for hybridisation onto the Affymetrix Mouse Gene 1.0 ST Array according to manufacturer's protocols. Scanning was performed on the Affymetrix GeneChip Scanner. For each time point four biological replicates were run in each group: cDNA from four individual Chd7 fl/fl ;Mesp1-Cre hearts was compared to cDNA from four Chd7 þ / þ ;Mesp1-Cre hearts. The data was normalised with the RMA normalisation algorithm using the Affy R package provided as part of the Bioconductor libraries (Gentleman et al., 2004 ) and analysed for differential expression using LIMMA (Smyth, 2004) . Data has been submitted to GEO (accession number GSE59963). The 100 significantly-altered genes with the highest fold changes from each up-or down-regulated list from the microarrays were uploaded to the DAVID Bioinformatics resource for GO analysis (Huang et al., 2009 ).
In situ hybridisation on paraffin sections
Plasmids for synthesising antisense RNA probes were kindly donated from the following sources: Sema3a and Sema3c from Christiana Ruhrberg; Robo2 from Gail Martin; and Slit2 from Bill Andrews (original clone from David Ornitz's lab). The Chd7 probe was generated using TOPO s TA Cloning s Kits (Life Technologies) with previously reported primers (Bosman et al., 2005) . Details for digoxigenin-labelling of probes, hybridisation and visualisation are included in the Supplemental material.
ChIP-PCR
Hearts were dissected from wildtype E11.5 CD1 embryos and sequentially fixed in 2 mM di(N-succinimidyl) glutarate (Sigma) for 45 min and 1% formaldehyde for 15 min. Hearts were quenched in 0.125 M glycine (Sigma) and washed in cold PBS. Tissue was lysed and passed through 21G and 23G needles five times each. Cells were pelleted by centrifugation and chromatin was released in 1% SDS buffer and sheared using a BioRuptor Sonicator (Diagenode), to an average size of 500 bp. All steps included 1 Â protease inhibitor cocktail (Roche).
ChIP was performed as described previously (Burney et al., 2013) with antibodies specific to CHD7 (#6505, Cell Signalling Technology) or non-specific rabbit IgG (Santa Cruz). Enrichment was analysed by real-time PCR performed using locus-specific primers (see Supplemental Material for sequences). Data were normalised to 5% input and compared to enrichment at non-specific loci.
DNase I hypersensitivity assay
Individual E11.5 hearts were dissected in cold PBS and incubated in 0.05% Trypsin-EDTA (Life Technologies) containing 10 mg/ml DNase I (Sigma) at 37°C for 45 min. Trypsin was inhibited with 10% FBS (Life Technologies) and samples passed through a 23G needle three times. Cells were pelleted by centrifugation and nuclei released in lysis buffer (10 mM Tris pH7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% NP40). Nuclei were treated with increasing concentrations of DNase I (Promega) at 37°C for 10 min. 25 mM EDTA was added to stop reactions and samples were RNaseA and Proteinase K treated, before purification using a Qiaquick PCR purification kit. Eluted DNA was quantified using a Qubit fluorometer (Life Technologies) and diluted to the same concentration, before RT-PCR analysis using primers designed around gene promoters (see Supplemental material for sequences).
Measurement of Ca 2 þ transients in embryonic cardiomyocytes
Individual Chd7 fl/fl , Chd7 fl/ þ or Chd7 fl/fl ;Mesp1-Cre E13.5 hearts were dissected in cold PBS and incubated in 0.05% Trypsin-EDTA (Life Technologies) containing 10 mg/ml DNase I (Sigma) at 37°C for 45 min. Trypsin was inhibited with 10% FBS (Life Technologies) and samples passed through a 23G needle three times. Cells were pelleted by centrifugation and resuspended in 1 ml culture medium (DMEM, 10% FCS, 1 Â PenStrep, 1 Â Non-essential amino acids) before plating for 1.5 h to allow adherence of fibroblasts. The supernatant containing cardiomyocytes was then plated onto laminin-coated (Sigma) coverslip dishes, and cells cultured at 37°C, 5% CO 2 for 36 h. Plating efficiency and survival of Chd7 fl/fl ; Mesp1-Cre cells did not appear compromised.
For imaging, cells were washed once in imaging buffer (156 mM NaCl, 3 mM KCl, 2 mM MgSO 4 Á 7H 2 0, 1.25 mM K 2 HPO 4 , 2 mM CaCl 2 , 10 mM HEPES, 10 mM D-Glucose, pH7.4) before incubation at 37°C for 10 min in imaging buffer/Opti-MEM s (50/50, Life Technologies) containing the Ca 2 þ -sensitive fluorogenic dye 5 mM Cal-520™ (Stratech). A Leica SP5 confocal inverted microscope performed rapid line scan analysis (400 Hz) of Ca 2 þ transients in individual cells (ex: 488 nm, em: 500-600 nm). Cells producing Ca 2 þ transients were chosen randomly and were electrically paced by field stimulation at 1 Hz using platinum electrodes. Data was collected and analysed by averaging values across the line, over time, using Leica LAS AF software. "Paced" cells were classified as those in which Ca 2 þ transients were observed every 1 Hz over a 40 s interval, whereas in "non-paced" cells, Ca 2 þ transients were absent or unsynchronised. p-values were calculated using two-tailed Fisher's exact test.
